India Set to Expedite Relief on Quality Norms as Sought by US and EU

India Set to Expedite Relief on Quality Norms as Sought by US and EU:

Amid flaring trade wars that have heightened the urgency for trade diversification globally, India has hinted at greater flexibility in accommodating trade concerns — such as quality control orders (QCOs) — raised by Western partners including the US, UK, EU, and New Zealand, all of whom are negotiating a trade deal with India, The Indian Express has learned.

This comes after the conclusion of initial talks between India and US when officials from the US were here in March to finalise the scope of the trade agreement. The US had then sought a range of commitments from the Indian side to ease market access for American goods into India.

In its report on foreign trade barriers, the United States Trade Representative (USTR) had particularly pointed out flaws in QCOs stating that the Bureau of Indian Standards (BIS) norms are “not always fully aligned with international standards” and “without a clear demonstration that the international standards would be ineffective or inappropriate”.

QCOs, which typically require foreign exporters and domestic producers to mandatorily meet specific quality norms, have been a source of major concern for both domestic manufacturers who import input materials and foreign countries looking to access the growing Indian market.

In recent years, India has dramatically ramped up the use of QCOs to prevent the influx of low-quality goods and simultaneously build a domestic manufacturing base, in tandem with schemes such as the Production Linked Incentive (PLI).

However, the US, EU, and UK have raised as many as 10 trade concerns over QCOs at the World Trade Organisation (WTO). These cover a range of products including furniture, automotive parts, man-made fibres, cookware and utensils, toys, chemicals, and footwear.

QCOs lack clear means of establishing conformity, alleged USTR

The USTR said QCOs often lack “clear means of establishing conformity” or involve significantly burdensome requirements. “For example, India requires chemicals to have BIS marks prior to importation, which necessitates a site visit to the manufacturing facility by an Indian inspector,” the USTR said.

“India’s National Pharmaceutical Pricing Authority (NPPA) caps prices of coronary stents and knee implants. US companies have raised concerns, noting that the price controls have not kept pace with inflation and do not differentiate based on production costs or technological innovation, which discourages US firms from serving the market,” the US flagged.

Earlier, the US had also asked India to “ensure” that QCOs “do not create unnecessary barriers to international trade”, in a trade concern raised over QCOs on chemicals and petrochemical products during a June 2024 meeting of a WTO committee. Similar concerns were raised by the US, EU, and five other countries.

At the same time, even the domestic industry has raised red flags over certain QCOs that apply to key input goods such as chemicals and man-made fibres. Domestic users of such goods have long called for these QCOs to be scrapped, arguing they restrict access to raw material imports and undermine export competitiveness.

🔍 Breaking News 

• India agrees to fast-track approvals for US/EU companies facing BIS/ISI certification delays
• Easier market access for 100+ products including medical devices, chemicals & tech goods
• US-India Trade Policy Forum demands resolved ahead of PM Modi’s possible 2024 US visit

📌 Key Changes

✔ Faster BIS certifications: 30-day deadline for testing results (Earlier: 3-6 months)
✔ Mutual recognition pacts: Accept EU/US lab reports for 57 product categories
✔ Auto sector boost: Luxury carmakers like Tesla to benefit from relaxed homologation

💡 Why It Matters

• $45B trade boost expected for US/EU firms in India
• Make in India 2.0: Eases compliance for Apple, Medtronic, Siemens suppliers
• Counter to China: Western firms get alternative to Chinese manufacturing

⚠️ Concerns

▸ Local manufacturers fear cheap imports may flood market
▸ FSSAI & CDSCO still maintain strict food/pharma standards

🌐 Global Reaction 

• US Trade Rep“Positive step for $200B trade target”
• EU Commission“Eases non-tariff barriers under FTA talks”

 


🔗 Strategic Links

External Sources:
bis.gov.inustr.gov/

tppustr.gov/tpp

trade.ec.europa.eu


 

Leave a Comment